What is the appropriate oral cephalexin dose for a 12.25 kg child, given at 25 mg per kilogram per dose twice daily for a 5–7‑day course?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Dosing for a 12.25 kg Child

For a 12.25 kg child receiving cephalexin at 25 mg/kg/dose twice daily, administer 306 mg (approximately 300 mg) per dose, which translates to 6 mL of the 250 mg/5 mL suspension twice daily for 5–7 days.

Dose Calculation

  • Weight-based calculation: 12.25 kg × 25 mg/kg = 306.25 mg per dose
  • Practical dosing: Round to 300 mg per dose (6 mL of 250 mg/5 mL suspension)
  • Frequency: Twice daily (every 12 hours)
  • Duration: 5–7 days

Context and Rationale

The 25 mg/kg/dose twice daily regimen you've specified is lower than standard guideline recommendations for most pediatric infections. The FDA-approved dosing and clinical guidelines typically recommend:

  • Standard pediatric dosing: 25–50 mg/kg/day divided into doses 1
  • For skin/soft tissue infections (MSSA): 75–100 mg/kg/day in 3–4 divided doses 2, 3
  • For most infections: The usual recommendation is 25–50 mg/kg/day in divided doses every 6–8 hours 1

Important Caveats

This twice-daily 25 mg/kg/dose regimen (total 50 mg/kg/day) may be suboptimal for serious infections. Recent pharmacokinetic studies support that:

  • For methicillin-susceptible Staphylococcus aureus (MSSA) with MIC ≤2 mg/L, twice-daily dosing of 22–45 mg/kg/dose can achieve pharmacodynamic targets 4
  • However, for MSSA with MIC of 4 mg/L, 80 mg/kg/dose twice daily is required 4
  • Three times daily dosing at 45 mg/kg/dose (maximum 1.5 g) has shown excellent efficacy and tolerability for bone and joint infections 5

Clinical Application

If this is for a mild infection (uncomplicated UTI, minor skin infection, or streptococcal pharyngitis in a child >1 year), the 25 mg/kg/dose twice daily may be acceptable.

If this is for a more serious infection (complicated skin/soft tissue infection, osteomyelitis, or confirmed MSSA bacteremia), consider:

  • Increasing to 25 mg/kg/dose three to four times daily (75–100 mg/kg/day total) 2, 3, 1
  • For this 12.25 kg child: 306 mg (6 mL) three times daily or four times daily depending on severity

Practical Administration

Using 250 mg/5 mL suspension 1:

  • Twice daily regimen: 6 mL every 12 hours
  • Three times daily regimen (if needed): 6 mL every 8 hours
  • Four times daily regimen (if needed): 6 mL every 6 hours

Store reconstituted suspension in refrigerator; discard after 14 days 1.

Monitoring

Watch for treatment failure indicators:

  • Persistent or worsening symptoms after 48–72 hours
  • Development of new fever or systemic signs
  • Gastrointestinal side effects (diarrhea occurs in ~5% of patients) 6
  • Mild neutropenia (uncommon but reported with higher doses) 5

The twice-daily 25 mg/kg/dose regimen provides convenience and may improve adherence 4, 7, but ensure the infection severity and pathogen susceptibility justify this less intensive dosing schedule.

Related Questions

What is the appropriate cephalexin dosage for an 11-year-old child weighing 95 lb (approximately 43 kg)?
What is the appropriate oral cephalexin dosing for a 17.4‑kg child with a full‑thickness scalp laceration?
What is the appropriate dose of cephalexin (Cephalixine) for a 5-year-old child?
What is the appropriate cephalexin (Keflex) dosing regimen for a child weighing 25.76 kg using the 125 mg/5 mL suspension?
What is the appropriate oral cephalexin (Keflex) dosing for a child weighing 31.3 kg?
What is the appropriate levodopa (L‑DOPA) dose in milligrams?
Should a contrast‑enhanced CT of the abdomen and pelvis be obtained to evaluate a suspected hernia, especially if there is concern for incarceration, strangulation, or bowel obstruction?
What is the appropriate management for a patient with a coronary angiogram showing a mid‑vessel acute 100 % thrombotic occlusion of the left anterior descending artery (LAD) (culprit lesion), left circumflex artery (LCx) with mid‑vessel disease and severe ostial obtuse‑marginal (OM) disease, right coronary artery (RCA) with mild diffuse disease and a severe distal right posterior descending artery (RPDA) lesion, and significantly elevated bilateral filling pressures?
How does cholecystectomy eradicate the Salmonella carrier state and serve as an alternative to ciprofloxacin?
What screening and tests are recommended for evaluating vertigo?
For a patient receiving Udenyca (pegylated liposomal doxorubicin) via daily syringe injections for two days, why choose the Udenyca On‑pro on‑body injector to avoid daily travel, and is there a major difference between the injector and syringe administration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.